Engineered transaminase polypeptides
AssigneeCodexis, Inc.
InventorsScott J. Novick, Nikki Dellas
Life of this patent
Estimating the term…
Abstract
The present disclosure provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The disclosure also provides polynucleotides encoding the engineered transaminase polypeptides, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases for the production of chiral amine compounds.
Claims20
An engineered transaminase comprising a polypeptide sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NOS:
- 8, 366, and/or 650, or a functional fragment thereof, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:
- 8, 366, and/or 650, and wherein the engineered transaminase exhibits an increase in percent conversion of a substrate to a product relative to an engineered transaminase having the amino acid sequence set forth in SEQ ID NO:366.
A polynucleotide sequence encoding at least one engineered transaminase comprising at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NOS:
- 8, 366, and/or 650, or a functional fragment thereof.
Dependencies are inferred from the claim text.